Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
RayzeBio, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
RayzeBio, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
APi Group CorpListing on record | Sell | $124.7K | SEC | ||
APi Group CorpListing on record | Sell | $6.1M | SEC | ||
APi Group CorpListing on record | Sell | $197.2M | SEC | ||
BridgeBio Pharma, Inc.Listing on record | Sell | $52.5M | SEC |